Navigation path

FP7 projects

print

List of project (sorted by Coordinator)


ANDRIA Generoso EUCLYD A European Consortium for Lysosomal Disorders
AYME Ségolène RAREDISEASEPLATFORM A European Platform of Integrated Information Services for Researchers in the Field of Rare Diseases and Orphan Drugs Supporting Team and Project Building.
BERRIH-AKNIN Sonia FIGHT-MG Myasthenias, a group of immune mediated neurological diseases: from etiology to therapy.
BOESPFLUG-TANGUY Odile LEUKOTREAT Therapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials
CROW Yanick NIMBL Nuclease Immune Mediated Brain and Lupus-like conditions (NIMBL): natural history, pathophysiology, diagnostic and therapeutic modalities with application to other disorders of autoimmunity
DEVUYST Olivier EUNEFRON European Network for the Study of Orphan Nephropathies
FERLINI Alessandra BIO-NMD Identifying and validating pre-clinical biomarkers for diagnostics and therapeutics of Neuromuscular Disorders
FRANCO Brunella EUCILIA Pathophysiology of rare diseases due to ciliary dysfunction: nephronophthisis, Oral-facial-digital type 1 and Bardet-Biedl syndromes
Francesco DI NARO Antonio PRATH Preclinical study of Recombinant human Anti-C5 for the Treatment of atypical HUS
GUENTHER Andreas EURIPFNET European IPF Network: Natural course, Pathomechanisms and Novel Treatment Options in Idiopathic Pulmonary Fibrosis
GRIMBACHER Bodo EURO-PADNET The Pathophysiology and Natural Course of Patients with Primary Antibody Deficiencies (PAD)
GONZALES-ASEGUINOLAZA Gloria AIPGENE Augmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria
GASSER Thomas MEFOPA European Project on Mendelian Forms of Parkinson's Disease
HIORT Olaf EURODSD Investigation of the molecular pathogenesis and pathophysiology of Disorders of Sex Development (DSD)
HUSEBYE Eystein EURADRENAL Pathophysiology and natural course of autoimmune adrenal failure in Europe
HERTL Michael PEMPHIGUS Pemphigus - From autoimmunity to disease
HOVNANIAN Alain GENEGRAFT Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector
JANKA Gritta CUREHLH European initiative to improve knowledge, treatment and survival of haemophagocytic syndromes in children
KOUTOUZOV Sophie E-RARE-2 ERA-Net on Rare Diseases
LARSSON Anders IMPACTT Immunoglobulin IgY pseudomonas A clinical trial for cystic fibrosis treatment
PETIT Christine TREATRUSH Fighting blindness of Usher syndrome: diagnosis, pathogenesis and retinal treatment (TreatRetUsher)
PANDOLFO Massimo EFACTS European Friedreich's Ataxia Consortium for Translational Studies
REILLY Mary MABSOT Development of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation
SAFTIG Paul ALPHA-MAN Rod-derived Cone ViabilityClinical development of Enzyme Replacement Therapy in alpha-Mannosidosis patients using recombinant human enzyme.
SAHEL José-Alain RDCVF Rod-derived Cone Viability Factor
TRIPEPI Giovanna PADDINGTON Pharmacodynamic Approaches to Demonstration of Disease-Modification in Huntington's Disease by SEN0014196
TOUITOU Isabelle EUROTRAPS Natural course, pathophysiology, models for early diagnosis, prevention and innovative treatment of TNF Receptor Associated Periodic Syndrome TRAPS with application for all hereditary recurrent fevers

Top ^